Skip to main content

Brazilian reference values for MPS II screening in dried blood spots--a fluorimetric assay.

Rezende MM, Müller KB, Pereira VG, D'Almeida V

Publication: Clin Biochem (2014) • Vol 47 • Page 1297-9PMID: 24979053View on PubMed

Purpose

The purpose of this paper was to determine the effects of patient gender, diagnosis, and assaying dried blood spots (DBS) rather than extracted leukocytes on the measurement of iduronate-2-sulfatase (IDS) activity. The effects of storing a DBS at 4°C for a year were also examined.

Conclusion

IDS activity was higher in specimens from healthy individuals than patients with Mucopolysaccharidosis II (MPS II, Hunter Syndrome). When assayed in DBS, the IDS activities measured in specimens from healthy individuals and patients with MPS overlapped, but when extracted leukocytes were assayed, there was no overlap in activity between specimens from healthy individuals and those with MPS II. Despite the overlap in values, DBS could be used to screen for MPS II with 100% sensitivity and 86.5% specificity. IDS activity was not significantly different in specimens from males than females. The authors report that when a single DBS was reassayed over the course of a year of storage at 4°C, the variability in IDS levels was 13.9%.

Studies (1)

Purpose

The purpose of this study was to determine the effects of patient gender, up to a year of refrigerated storage, and assaying DBS rather than extracted leukocytes on measurement of IDS activity in blood from 52 healthy individuals and 21 MPS patients. DBS were prepared by dropping blood onto filter paper and allowing it to dry at room temperature for at least 4 h before refrigerated storage for an unspecified duration. The remainder of each blood specimen was then refrigerated for up to 48 h before leukocyte extraction.

Summary of Findings

IDS activity was higher in specimens from healthy individuals than from patients with MPS II. When assayed in DBS, the IDS activity in specimens from healthy individuals and patients with MPS overlapped (1.83-16.86 umol/L/h and 0.58-4.32 umol/L/h, respectively), but when extracted leukocytes were assayed, there was no overlap between levels in specimens from healthy individuals and those with MPS II (2.71-17.36 mmol/mg protein/h and 0-0.11 mmol/mg protein/h, respectively). Despite the overlap in values, DBS could be used to screen for MPS II with 100% sensitivity and 86.5% specificity. IDS activity was not significantly different in specimens from males than females. The authors report that when a single DBS was reassayed over the course of a year of storage at 4°C, the variability in IDS levels was 13.9%.

  • Biospecimens

    FluidBlood
    CellWhite Cells
  • Preservation Types

    Other Preservative
  • Diagnoses

    Normal
    Other diagnoses
  • Platforms

    ProteinFluorometry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Healthy
    MPSII
    PreaquisitionPatient gender
    Female
    Male
    Biospecimen Aliquots and ComponentsBlood and blood products
    Leukocyte
    Whole blood
    Biospecimen PreservationType of fixation/preservation
    Air-dried
    Refrigeration
    StorageStorage duration
    0-1 year